本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

6.66
+0.59009.72%
成交量:7.20万
成交额:46.12万
市值:4,098.30万
市盈率:-0.68
高:6.73
开:5.88
低:5.81
收:6.07
52周最高:46.80
52周最低:3.76
股本:615.36万
流通股本:300.20万
量比:1.07
换手率:2.40%
股息:- -
股息率:- -
每股收益(TTM):-9.7606
每股收益(LYR):-20.9448
净资产收益率:-141.82%
总资产收益率:-54.70%
市净率:0.57
市盈率(LYR):-0.32

数据加载中...

2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/06

重要事件披露

Form 8-K - Current report
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/04/02

SEC问询函

Form CORRESP - Correspondence
2025/03/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/02/12

重要事件披露

Form 8-K - Current report
2025/02/03

重要事件披露

Form 8-K - Current report
2024/11/15

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]